Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21454690rdf:typepubmed:Citationlld:pubmed
pubmed-article:21454690lifeskim:mentionsumls-concept:C0007603lld:lifeskim
pubmed-article:21454690lifeskim:mentionsumls-concept:C1420175lld:lifeskim
pubmed-article:21454690lifeskim:mentionsumls-concept:C1426056lld:lifeskim
pubmed-article:21454690lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:21454690lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:21454690lifeskim:mentionsumls-concept:C1326474lld:lifeskim
pubmed-article:21454690lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:21454690lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:21454690lifeskim:mentionsumls-concept:C2827421lld:lifeskim
pubmed-article:21454690pubmed:issue19lld:pubmed
pubmed-article:21454690pubmed:dateCreated2011-5-9lld:pubmed
pubmed-article:21454690pubmed:abstractTextAS160 (TBC1D4) is a known Akt substrate that is phosphorylated downstream of insulin action and that leads to regulated traffic of GLUT4. As GLUT4 vesicle fusion with the plasma membrane is a highly regulated step in GLUT4 traffic, we investigated whether AS160 and 14-3-3 interactions are involved in this process. Fusion was inhibited by a human truncated AS160 variant that encompasses the first N-terminal phosphotyrosine-binding (PTB) domain, by either of the two N-terminal PTB domains, and by a tandem construct of both PTB domains of rat AS160. We also found that in vitro GLUT4 vesicle fusion was strongly inhibited by the 14-3-3-quenching inhibitors R18 and fusicoccin. To investigate the mode of interaction of AS160 and 14-3-3, we examined insulin-dependent increases in the levels of these proteins on GLUT4 vesicles. 14-3-3? was enriched on insulin-stimulated vesicles, and its binding to AS160 on GLUT4 vesicles was inhibited by the AS160 tandem PTB domain construct. These data suggest a model for PTB domain action on GLUT4 vesicle fusion in which these constructs inhibit insulin-stimulated 14-3-3? interaction with AS160 rather than AS160 phosphorylation.lld:pubmed
pubmed-article:21454690pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:languageenglld:pubmed
pubmed-article:21454690pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:citationSubsetIMlld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21454690pubmed:statusMEDLINElld:pubmed
pubmed-article:21454690pubmed:monthMaylld:pubmed
pubmed-article:21454690pubmed:issn1083-351Xlld:pubmed
pubmed-article:21454690pubmed:authorpubmed-author:HolmanGeoffre...lld:pubmed
pubmed-article:21454690pubmed:authorpubmed-author:KoumanovFranç...lld:pubmed
pubmed-article:21454690pubmed:authorpubmed-author:RichardsonJud...lld:pubmed
pubmed-article:21454690pubmed:authorpubmed-author:MurrowBeverle...lld:pubmed
pubmed-article:21454690pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21454690pubmed:day13lld:pubmed
pubmed-article:21454690pubmed:volume286lld:pubmed
pubmed-article:21454690pubmed:ownerNLMlld:pubmed
pubmed-article:21454690pubmed:authorsCompleteYlld:pubmed
pubmed-article:21454690pubmed:pagination16574-82lld:pubmed
pubmed-article:21454690pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:meshHeadingpubmed-meshheading:21454690...lld:pubmed
pubmed-article:21454690pubmed:year2011lld:pubmed
pubmed-article:21454690pubmed:articleTitleAS160 phosphotyrosine-binding domain constructs inhibit insulin-stimulated GLUT4 vesicle fusion with the plasma membrane.lld:pubmed
pubmed-article:21454690pubmed:affiliationDepartment of Biology and Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom.lld:pubmed
pubmed-article:21454690pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21454690pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed